Financial PR and IR for smallcap and AIM companies
London
Joined May 2009
- Tweets15.6K
- Following663
- Followers2.1K
- Likes991
⬆️Greater automation reduces delivery time and increases capacity,
👏The platform is currently being trialled by several customers across Chile, Singapore, the United States and the United Kingdom ahead of the planned commercial launch in December.
RNS -
londonstockexchange.com/news…
Harin Vaghela, Chief Product Officer, provides an overview of the new Invention Evaluator platform -
youtube.com/embed/cF1PR2mpbS…
➡️@edenresearch - Attendance at Annual Biocontrol Industry Meeting
👥#EDEN commercial team, including Sean Smith, CEO, and Alex Abrey, CFO, will be attending ABIM in Basel, Switzerland from 20 to 22 October 2026
🌍Leading international event for global biocontrol industry
⏩@TristelGlobal (AIM: #TSTL) - Research Summary
Cavendish view: (TP: 560.0p) Results aligned with the July trading update. Tristel closed FY26 with cash and equivalents of £16.0m, no debt and a final dividend of 9.23p.
Cavendish believe the current c3.5% dividend yield is attractive, given the expected growth and profitability of the company.
The full note is available below ⬇️
Cavendish Portal - cavendish.com/research-porta…
Research Tree - research-tree.com/providers/…
"Enormous potential for @TristelGlobal to continue growing sales, especially in the US market" - Ian Conway writes on #TSTL for @Sharesify
sharesify.com/tristel-posts-…
➡️@TristelGlobal (AIM: #TSTL) - Audited Results
📈Turnover +10% to £51.1m (2025: £46.5m)
✅Adj. pre-tax profits +15% to £11.7m (2025: £10.1m)
💰Cash & short-term investment balance of £16.0m (2025: £12.8m)
🚀Debt free with strong cash generation
👥Appointment of Chris Lee as CEO
📽️ A video overview of the results from Chris Lee, CEO, and Anna Wasyl, CFO, is available here - brrmedia.co.uk/broadcasts-em…
🔗 londonstockexchange.com/news…
REMINDER: @TristelGlobal (AIM: #TSTL) will report its financial results on Monday 19 October 2026
👏 Chris Lee, CEO, & Anna Wasyl, CFO, will present the results in two separate events on Monday, open to all investors. The same presentation will be given at both events
🗣️ Live online presentation via Investor Meet Company
🕚 11:00am
➡️ Sign up via the link here - investormeetcompany.com/comp…
⏩ In-person presentation
🕟 4:30pm
📍 City of London
➡️ To attend please contact Walbrook PR via [email protected] or 020 7933 8780
🏅 Congratulations to @onehealthgroup for being shortlisted for Scale-Up of the Year (£10m+) award!
🎉 The Yorkshire Growth awards recognise ambitious businesses, teams and individuals driving growth across the region.
#OHGR
thebusinessdesk.com/yorkshir…
@Parsortix (AIM: #CLBX) - Signs New Statement of Work with US-Based Pharmaceutical Company
✅New SOW under existing MSA with a US-based pharmaceutical company
⬆️Valued at US$65,000
📈Contract reflects continued engagement with an established pharmaceutical customer
⏩@Abingdon_Health (AIM: #ABDX) - Final Results
⬆️Revenue up 30% to £11.0m
👍Adjusted EBITDA loss improved to
💰Cash and cash equivalents of £2.9m
📈Admitted to trading in New York on the OTCQB Venture Market under the ticker symbol "ABDXF"
